Streetbeat News

Stock Prices

LGVN

Longeveron shares are trading higher following the circulation of a Zacks Small Cap Research report that values the company at $15.10 per share.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:35 pm

VKTX

Deep-pocketed investors have shown unusual bearish options activity for Viking Therapeutics (NASDAQ:VKTX), with 66% of the trades being bearish. This significant move suggests potential upcoming volatility for VKTX. The stock is currently trading at $53.48, up by 1.42%, with the next earnings report due in 42 days.

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 3:32 pm

SNOW

Deep-pocketed investors are showing significant interest in Snowflake (NYSE:SNOW) with a notable amount of options activity. The sentiment among these investors is mixed, with 48% bullish and 24% bearish. Analysts have varied ratings on the stock, with target prices ranging from $190 to $240.

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 3:31 pm

BIIB

LLY

At the Goldman Sachs Conference, a Biogen executive stated that the Alzheimer's drug market will develop faster with Eli Lilly's involvement. However, the executive refrained from speculating on the future of Donanemab's label.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:30 pm

BIIB

LLY

Biogen's executive expressed confidence in the success of their Alzheimer's drug, LEQEMBI, regardless of competition. The executive also mentioned that Eli Lilly's experimental Alzheimer's drug will help grow the market. This was stated at the Goldman Sachs Conference.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:28 pm

SPY

TLT

May's inflation report showed a deceleration to 3.3% year-over-year, lower than expected. This has increased confidence in the Federal Reserve's ability to manage inflation and has led to positive market reactions. Economists from Bank of America, Comerica, RSM US LLP, Allianz Investment Management, NorthEnd Private Wealth, and LPL Financial provided insights on the potential impact on future Fed rate cuts.

Portfolio Pulse from Piero Cingari

June 12, 2024 | 3:25 pm

BTCUSD

DOGEUSD

PEPEUSD

SHIBUSD

Lower-than-expected CPI data has boosted Bitcoin's price, leading to a 3% increase in global crypto market capitalization. This has raised hopes for interest rate cuts ahead of a pivotal Fed meeting. Bitcoin spiked to $69,600, with altcoins like Dogecoin, Pepe, and Shiba Inu also seeing gains.

Portfolio Pulse from Khyathi Dalal

June 12, 2024 | 3:21 pm

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SLV

SPY

TSLA

USO

The stock market is reacting positively to cooler-than-expected CPI data, with significant buying in AI stocks and major tech companies. The probability of a rate cut by the Fed in September is now 55%, and 90% by December. Inflation in China is also falling, which helps lower U.S. inflation. The International Energy Agency predicts an oil surplus by 2030. Bitcoin is rallying on lower CPI. Investors are advised to maintain a balanced protection band to manage risk.

Portfolio Pulse from The Arora Report

June 12, 2024 | 3:18 pm

LRCX

Financial giants have made significant bearish moves on Lam Research (NASDAQ:LRCX) through options trading. Analysis revealed 27 unusual trades, with 37% bullish and 44% bearish. The price target for LRCX ranges from $590 to $1420. Current trading volume is 456,021, with the stock up 2.75% at $1027.2. Analysts have mixed ratings, with price targets ranging from $900 to $1060.

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 3:16 pm

RNA

Avidity Biosciences (NASDAQ:RNA) shares surged 33.5% following positive results from the Phase 1/2 FORTITUDE trial for treating facioscapulohumeral muscular dystrophy (FSHD) with delpacibart braxlosiran. The trial showed significant functional improvements and good tolerance, offering hope for FSHD patients.

Portfolio Pulse from Dylan Berman

June 12, 2024 | 3:15 pm